Cobus Loots, CEO of Pan African Resources, on delivering sector-leading returns for shareholders. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMarwyn Acqn Ii Regulatory News (MAC2)

Share Price Information for Marwyn Acqn Ii (MAC2)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 0.00
Bid: 0.00
Ask: 0.00
Change: 0.00 (0.00%)
Spread: 0.00 (0.00%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 0.00
MAC2 Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Annual Financial Report

24 Oct 2022 07:00

RNS Number : 7885D
Marwyn Acquisition Company II Ltd
24 October 2022
 

THIS ANNOUNCEMENT AND THE INFORMATION CONTAINED HEREIN IS NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, CANADA, THE REPUBLIC OF SOUTH AFRICA, JAPAN, ANY MEMBER STATE OF THE EUROPEAN ECONOMIC AREA OR ANY JURISDICTION IN WHICH IT WOULD BE UNLAWFUL TO DO SO

 

LEI: 2549008KZ7HM27V4O637

 

Marwyn Acquisition Company II Limited

(the "Company")

Publication of the Financial Statements for the period ended 30 June 2022

 

The Company announces the publication of its results for the period ended 30 June 2022.

 

The Financial Statements are also available on the 'Shareholder Documents' page of the Company's website at www.marwynac2.com.

 

Enquiries: 

 

Company Secretary

Antoinette Vanderpuije - 020 7004 2700

 

Finsbury - PR Adviser 

Rollo Head 07768 994 987 

Chris Sibbald 07855 955 531 

 

Investec Bank plc - Financial Adviser 020 7597 5970 

Christopher Baird 

Carlton Nelson 

Alex Wright 

 

N.M. Rothschild & Sons Limited - Financial Adviser 020 7280 5000

Peter Nicklin

Shannon Nicholls

 

WH Ireland Limited - Corporate Broker - +44 (0) 207 220 1666

Harry Ansell

Katy Mitchell

 

 

MARWYN ACQUISITION COMPANY II LIMITED

Consolidated Financial StatementsFor the year ended 30 June 2022

 

 

MANAGEMENT REPORT

 

We present to shareholders the audited consolidated financial statements of Marwyn Acquisition Company II Limited (the "Company") for the year ended 30 June 2022 (the "Financial Statements"), consolidating the results of Marwyn Acquisition Company II Limited and its subsidiary, MAC II (BVI) Limited (collectively, the "Group").

 

Strategy

Marwyn Acquisition Company II is an acquisition vehicle listed on the standard segment of the London Stock Exchange. The vehicle is led by Chairman Mark Hodges, who was previously CEO of ReAssure, prior to which he held senior executive plc board positions at a number of large financial services and consumer businesses including Centrica, Towergate and Aviva.

The Company is backed by Marwyn who have launched 11 previous comparable acquisition vehicles that have acquired platform businesses, which include Advanced Computer Software, BCA Marketplace, Breedon Aggregates and Entertainment One.

The company is pursuing its stated investment strategy of seeking acquisition opportunities in the financial services, consumer and technology sectors.

The Directors believe that the current market backdrop has, amongst a range of drivers, four notable interrelated themes, shaping a clear customer need that remains largely unmet.

1. Changing Population and demographics

Per recent estimates, there are currently 21 million people aged 55 and over in the UK (2020) and 99 million people aged 55 and over in the US (2021). This global trend is likely to have a significant impact on economies, social care systems and household finances and the Directors believe future financial solutions will need to reflect an increasing level of intergenerational financial and social dependencies with financial products, advice and life solutions needing to be tailored to meet a spectrum of complex multi-generational needs.

 

2. Wealth transfer and the role of families

Intergenerational wealth transfer is expected to exceed US$68 trillion, with £5.5 trillion of this in the UK, underpinning the increasing importance of the role played by families in providing future financial solutions.

· In the UK, one in every two first-time buyers aged under 35 is receiving financial support from their parents;

· 71% of these new homeowners say they would not have been likely to buy without financial support from family or friends;

· 75% of parents provide financial support to children who have left home;

· 43% of parents with children aged 30+ say they are helping them financially;

· In the US in 2018, families and friends supported one in every five existing home buyers with the purchase of 1.2 million homes, financing US$317 billion worth of homes; and

· US parents are spending US$500 billion on their adult children per annum.

 

3. Social and non-financial family support

· 5.4 million people in the UK provide unpaid care for a friend or family member with over 1.4 million people providing fifty or more hours of care per week. The peak age of carers in the UK is 55-64 with 29% of adults providing care and 22% of people aged over 65 providing unpaid care.

· In the US, where 53 million people are providing unpaid care to an adult with health or functional needs. 61% of these carers are fully employed and 45% say caregiving had at least one financial impact (e.g. stopped saving or took on more debt).

· 10 million caregivers (25% of US caregivers) fall into the millennial age range (22-37), of which, 73% are employed but also spend an average of 21 hours a week caring for loved ones.

 

4. Concentration of wealth

· In the UK, household wealth is principally concentrated in property (36%) and pension assets (42%);

· In the US, household wealth is similarly concentrated in pensions (20%), real estate (24%) and equities (27%).

 

Opportunities for a new approach to family-focussed financial solutions

With the combination of these social and macroeconomic conditions and trends, the Directors believe all generations are facing increasingly challenging financial situations which are creating several problems to be solved. The Directors believe there is a well-defined need and opportunity, now more than ever, for clear and impartial support and solutions to be provided to, and shared amongst, friends, family and peers.

 

Strategy Execution

The Company intends to execute its strategy through a combination of selective M&A of platform and bolt-on businesses, potential strategic partnerships with established financial services operators as well as ongoing operational improvements. Target company market segments, principally expected to be in the UK and US, may include, but are not limited to:

· FinTech digital platforms;

· Digital content platforms;

· Life and pensions;

· Life-insurance assets;

· Lifetime mortgages and equity release;

· Wealth managers and advisers;

· Brokerage and associated services;

· Mortgage advisory;

· Healthcare related services;

· Estate planning and associated legal and tax services; and

· Later life planning and assisted care services.

 

Activity

The Company was incorporated on 31 July 2020 and subsequently listed on the Main Market of the London Stock Exchange on 4 December 2020. The Company has been formed for the purpose of effecting a merger, share exchange, asset acquisition, share or debt purchase, reorganisation or similar business combination with one or more businesses. The Company's objective is to generate attractive long term returns for shareholders and to enhance value by supporting sustainable growth, acquisitions and performance improvements within the acquired companies.

On 29 March 2022, the Company announced the launch of a 12-month placing programme (the "Placing Programme") pursuant to which the Company has the ability to issue up to 500 million C ordinary redeemable shares ("C Shares") at an issue price of £1 per C share in order to raise up to an aggregate of £500 million.

On 20 June 2022, the Company announced the appointment of Mark Hodges as Chairman. In connection with this appointment, the strategy of the Company was refined as set out above. Mark Hodges' biography is set out on page 4. During the year and to the date of this report, the Company has continued to assess potential acquisition opportunities in line with its stated strategy.

 

Results The Group's total comprehensive loss for the year to 30 June 2022 was £1,934,518 (period ended 30 June 2021: £636,096). Of the costs incurred in the year, £793,214 (period ended 30 June 2021: £263,769) relates to non-recurring project costs. The Group held a cash balance at the year end of £10,254,198 (2021: £12,255,387). The Group has not yet acquired an operating business and as such is not yet income generating.

In connection with the Company's ongoing activities, an asset has been recorded for costs associated with a further equity raise at the balance sheet date as disclosed in Note 10. There is currently no certainty that the potential capital raise will take place nor of its terms should it do so.

 

Directors

The Directors during the year and subsequently are:

Mark Hodges (Chairman) - appointed 19 June 2022

James Corsellis - stepped down as Chairman effective 19 June 2022 and remains a director of the Company

Mark Brangstrup Watts

 

Directors' Biographies

Mark Hodges

Mark Hodges is the Chairman of the Company and has over 30 years' experience across the financial services and consumer sectors, including extensive FTSE 100 PLC board experience with Centrica plc and Aviva plc. As former CEO of ReAssure, Mark led the business through the £425m acquisition of Quilter's UK Heritage business and oversaw the sale of Reassure to Phoenix Group Holdings in 2020 for £3.25bn. At the time of the sale, ReAssure had approximately £80bn of assets under administration, 4 million customers and approximately 2,500 employees.

Previously, Mark was CEO of Centrica's £11bn revenue consumer division, which included British Gas in the UK, Bord Gais in Ireland, Direct Energy in the US and Hive globally. Mark was hired from outside the energy sector as a change agent to simplify and modernise the business to make it more efficient, more customer-focused and less product-led. Mark's mandate included the improvement of digital channels, the growth of new revenue streams, and to drive cultural change. During his tenure, Mark oversaw a growth in the Hive customer base from approximately 200,000 customers to more than 1.3 million.

Before this, Mark led Towergate Insurance, a 5,000-employee business with revenue of more than £400m and serving approximately 2 million customers. Mark was responsible for formulating the group strategy and oversaw the acquisition of 50 specialist insurance businesses, significantly bolstered the new executive team and management below executive level, oversaw the complete rebuild of governance and operational control frameworks to bring in line with regulatory standards, and carried out a fundamental operational restructuring, including the establishment of a market leading 400 person contact centre in Manchester.

Mark previously spent more than 20 years with Aviva across a variety of senior finance, planning and strategy roles, including CEO of UK Life and Pensions and latterly as Aviva UK Chief Executive and board member of Aviva plc. As CEO of Aviva UK, Mark led a business with annual revenues of £15bn, £1.4bn in operating profits, and approximately 20,000 staff. Mark's highlights at Aviva include the creation of a new strategy for the UK business and implementation of a new operating model to create the largest composite insurer in the UK that saw a return to growth of the General Insurance business, developing a vision for the integrated UK business that generated significant annual cost savings and led to sustained outperformance of the UK Life Business, and leading the turnaround in the UK Life Insurance business to deliver growth, reduced costs, improved profitability, improved customer service (NPS), and improved people engagement as well as overseeing the brand change from Norwich Union to Aviva. During his tenure with Norwich Union, Mark was involved in the acquisition of London & Edinburgh in 1996, demutualised and floated Norwich Union on the London Stock Exchange in 1997 and merged with CGU in 2000. He subsequently oversaw the acquisition of RAC PLC in 2005 for £1.25bn

James Corsellis

James brings extensive public company experience as well as management and corporate finance expertise across a range of sectors and an extensive network of relationships with co-investors, advisers and other business leaders.

Previously James has served as a director of the following companies: a non-executive director of BCA Marketplace Limited (formerly BCA Marketplace Plc) from July 2014 to December 2017, Advanced Computer Software from October 2006 to August 2008, non-executive chairman of Entertainment One Limited from January 2007 to March 2014 and remaining on the board as a non-executive director until July 2015, non-executive director of Breedon Aggregates Limited from March 2009 to July 2011 and as CEO of icollector Plc from 1994-2001 amongst others. James was educated at Oxford Brookes University, the Sorbonne and London University.

James is a managing partner of Marwyn Capital LLP and Marwyn Investment Management LLP, an executive director of Silvercloud Holdings Limited, and the chairman of Marwyn Acquisition Company Plc, Marwyn Acquisition Company III Limited and MAC Alpha Limited.

 

Mark Brangstrup Watts

Mark has many years of experience deploying long term investment strategies in the public markets. Mark brings his background in strategic consultancy to the management team, having been responsible for strategic development projects at a range of international companies including Ford Motors Company (US), Cummins (Japan) and 3M (Europe).

Previously Mark has served a director of the following companies: a non-executive director of Zegona Communications Plc from January 2015 to May 2020, BCA Marketplace Limited (formerly BCA Marketplace Plc) from July 2014 to December 2017, Advanced Computer Software from October 2006 to September 2012, Entertainment One Limited from June 2009 to July 2013, Silverdell Plc from March 2006 to December 2013, Inspicio Holdings Limited from October 2005 to February 2008 and Talarius Limited September 2005 to February 2007 amongst others. Mark has a BA in Theology and Philosophy from King's College, London.

Mark is a managing partner of Marwyn Capital LLP and Marwyn Investment Management LLP, an executive director of Silvercloud Holdings Limited, and a director of Marwyn Acquisition Company Plc, Marwyn Acquisition Company III Limited, MAC Alpha Limited and AdvancedAdvT Limited.

 

Dividend Policy

The Company has not yet acquired a trading business and it is therefore inappropriate to make a forecast of the likelihood of any future dividends. The Directors intend to determine the Company's dividend policy following completion of an acquisition and, in any event, will only commence the payment of dividends when it becomes commercially prudent to do so.

 

Key Performance Indicators

The Company has not yet acquired a trading business and therefore no key performance indicators have been set as it is inappropriate to do so.

 

Stated Capital

Details of the stated capital of the Company during the year are set out in Note 14 to the Financial Statements.

On 4 December 2020 the Company issued 700,000 ordinary shares and matching warrants for a total price of £700,000. 75% of the ordinary shares and matching warrants were issued to an entity managed by Marwyn Investment Management LLP ("MIM LLP"), the remaining 25% were issued to senior executive managers of previous successful acquisition companies launched by Marwyn.

On 20 April 2021, the Company issued 12 million A shares to an entity managed by MIM LLP (with class A warrants being issued on the basis of one class A warrant per A share), for a total price of £12,000,000.

On 29 March 2022, the Company announced the launch of the Placing Programme pursuant to which the Company has the ability to issue up to 500 million C Shares at an issue price of £1 per C share in order to raise up to an aggregate of £500 million. As at the date of these Financial Statements, no C Shares have been issued.

 

Corporate Governance

As a company with a Standard Listing, the Company is not required to comply with the provisions of the UK Corporate Governance Code and given the size and nature of the Group the Directors have decided not to adopt the UK Corporate Governance Code. Nevertheless, the Board is committed to maintaining high standards of corporate governance and will consider whether to voluntarily adopt and comply with the UK Corporate Governance Code as part of any acquisition, taking into account the Company's size and status at that time.

 

The Company currently complies with the following principles of the UK Corporate Governance Code:

· The Company is led by an effective and entrepreneurial Board, whose role is to promote the long term sustainable success of the Company, generating value for shareholders and contributing to wider society;

· The Board ensures that it has the policies, processes, information, time and resources it needs in order to function effectively and efficiently; and

· The Board ensures that the necessary resources are in place for the company to meet its objectives and measure performance against them.

Given the size and nature of the Company, the Board has not established any committees and intends to make decisions as a whole. If the need should arise in the future, for example following any acquisition, the Board may set up committees and may decide to comply with the UK Corporate Governance Code.

 

Risk management and internal control systems

A robust risk assessment was carried out by the Directors of the Company, along with its advisers, in preparation for the Company's IPO on 4 December 2020 and the Directors have identified a wide range of risks, which are set out in the Company's prospectus dated 4 December 2020. As part of the launch of the Placing Programme an updated robust risk assessment was carried out by the Directors of the Company, along with its advisers and the wide range of risks identified are set out in the Company's prospectus dated 31 March 2022.

The Company's prospectuses are available on the Company's website: www.marwynac2.com.

The Company's risk management framework incorporates a risk assessment that identifies and assesses the strategic, operational and financial risks facing the business and mitigating controls. The risk assessment is documented through a risk register which categorises the key risks faced by the business into:

· Business risks;

· Shareholder risks;

· Financial and procedural risks; and

· Risks associated with the acquisition process.

The risk assessment identifies the potential impact and likelihood of each of the risks detailed on the risk register and mitigating factors/actions have also been identified.

The Company's risk management process includes both formal and informal elements. The size of the Board and the frequency in which they interact ensures that new risks, or changes to the nature of the Company's existing risks, are identified, discussed and analysed quickly. The Company's governance framework, including formal periodic board meetings with standing agendas, ensures that the Company has a formal framework in place to manage the review, consideration and formal approval of the risk register, including risk assessment.

The Group's only significant asset is cash. As at the statement of financial position date the Group's cash balance was £10,254,198 (2021: £12,255,387). Price, credit, liquidity and cashflow risk are not considered to be significant due to the simple nature of the Company's assets and liabilities and the current activities undertaken by the Group. The Directors have reviewed the risk of holding a singular concentration of assets and do not deem this a material risk, as set out in Note 16 of these financial statements. The Directors have set out below the principal risks faced by the business. These are the risks the Directors consider to be most relevant to the Company based on its current status. The risks referred to below do not purport to be exhaustive and are not set out in any particular order of priority.

 

Key risk

Explanation

The Company could incur costs for transactions that may ultimately be unsuccessful.

There is a risk that the Company may incur substantial legal, financial and advisory expenses arising from unsuccessful transactions which may include public offer and transaction documentation, legal, accounting and other due diligence which could have a material adverse effect on the business, financial condition, results of operations and prospects of the Company.

The Company may not be able to complete an acquisition.

 

The Company's future success is dependent upon its ability to not only identify opportunities but also to execute a successful acquisition. There can be no assurance that the Company will be able to conclude agreements with any target business and/or shareholders in the future and failure to do so could result in the loss of an investor's investment. In addition, the Company may not be able to raise the additional funds required to acquire any target business, fund future operating expenses after the initial twelve months, or incur the expense of due diligence for the pursuit of acquisition opportunities in accordance with its investment objective.

The Company may face significant competition for acquisition opportunities.

 

There may be significant competition for some or all of the acquisition opportunities that the Company may explore. Such competition may for example come from strategic buyers, sovereign wealth funds, special purpose acquisition companies and public and private investment funds, many of which are well established and have extensive experience in identifying and completing acquisitions. A number of these competitors may possess greater technical, financial, human and other resources than the Company. Therefore, the Company may identify an investment opportunity in respect of which it incurs costs, for example through due diligence and/or financing, but the Company cannot assure investors that it will be successful against such competition. Such competition may cause the Company to incur significant costs but be unsuccessful in executing an acquisition or may result in a successful acquisition being made at a significantly higher price than would otherwise have been the case which could materially adversely impact the business, financial condition, result of operations and prospects of the Company.

Even if the Group completes the Business Acquisition, any technological, strategic, operating and financial improvements proposed and implemented may not be successful.

The success of any of the Group's acquisitions may depend in part on the Group's ability to implement the necessary technological, strategic, operational and financial change programmes in order to transform the acquired business and improve its financial performance. Implementing change programmes within an acquired business may require significant modifications, including changes to hardware and other business assets, operating and financial processes and technology, software, business systems, management techniques and personnel, including senior management.

 

There is no certainty that the Group will be able to successfully implement such change programmes within a reasonable timescale and cost, and any inability to do so could have a material adverse impact on the Company's performance and prospects.

 

Specifically, in the context of operational improvements and financial performance, the Company may not be able to propose and implement effective operational improvements for the target business with which the Group completes an acquisition. Such target businesses may not be able to generate the expected margins or cash flows. Although the Group assesses each target business, these assessments are subject to a number of assumptions and estimates concerning markets, profitability, growth, interest rates and company and asset valuations. The Group's assessments of, and assumptions regarding, target businesses may prove to be incorrect and actual developments may differ significantly from the Group's expectations. In addition, even if the Group completes an acquisition, general economic and market conditions or other factors outside the Company's control make the Company's operating strategies difficult or impossible to implement.

 

Directors interests

The Directors have no direct interests in the ordinary shares of the Company. The Directors have interests in the Company's long term incentive plan, as detailed in Note 17 to the Financial Statements. James Corsellis and Mark Brangstrup Watts are managing partners of MIM LLP which manages 75% per cent of the ordinary shares and matching warrants, and 100% of the A shares and matching A warrants issued by the Company. James Corsellis and Mark Brangstrup Watts are also managing partners of Marwyn Capital LLP, a firm which provides corporate finance, company secretarial and ad-hoc managed services support to the Company. Details of the related party transactions which occurred during the year are disclosed in Note 18 to the Financial Statements, save for the participation in the Company's long term incentive plan as disclosed in Note 17 to the Financial Statements. There were no loans or guarantees granted or provided by the Company and/or any of its subsidiaries to or for the benefit of any of the Directors.

 

Statement of Going Concern

The Financial Statements have been prepared on a going concern basis, which assumes that the Group will continue to be able to meet its liabilities as they fall due for the foreseeable future. The Directors have considered the financial position of the Group and have reviewed forecasts and budgets for a period of at least 12 months following the approval of the Financial Statements.

At 30 June 2022, the Group has net assets of £8,247,216 (2021: £10,180,565) and a cash balance of £10,254,198 (2021: £12,255,387). The Company has sufficient resources to continue to pursue its investment strategy which may include effecting a merger, share exchange, asset acquisition, share or debt purchase, reorganisation or similar business combination with one or more businesses. Subject to the structure of any acquisition, the Company may need to raise additional funds to finance the acquisition in the form of equity and/or debt. The capital structure of the Company enables it to issue different types of shares in order to raise equity to fund an acquisition. As set out in the Management Report, during 2022, the Company has launched the PlacingProgramme, under which the Company has the ability to raise up to £500 million via the issuance of C Shares. No C Shares have yet been issued as at the date of these Financial Statements. The Company can also raise capital via the issuance of further ordinary shares or via the issuance of unlisted B shares which would be issued in conjunction with a private placement memorandum to qualifying institutional investors, and exchangeable into listed ordinary shares on re-admission. The ability of the Company to raise additional funds in relation to an acquisition may affect its ability to complete that acquisition. Other factors outside of the Company's control may also impact on the Company's ability to complete that acquisition. The key risks relating to the Company's ability to execute its stated strategy are set out on page 7. 

The Company also entered into a forward purchase agreement ("FPA") on 27 November 2020 with Marwyn Value Investors II LP (''MVI II LP'') of up to £20 million, which may be drawn for general working capital purposes and to fund due diligence costs. Any drawdown is subject to the prior approval of MVI II LP and the satisfaction of conditions precedent. At 30 June 2022 £12 million had been drawn down under the FPA. Whilst the FPA provides a mechanism for the Company to raise additional funds, as any drawdown is not under the exclusive control on the Company, all cashflow and working capital forecasts have been prepared without any further draw down on the FPA being assumed.

Furthermore, the Directors have considered the ongoing impact of the Covid-19 pandemic, conflict in Ukraine and current macro-economic factors on the Group's forecast cashflows and liabilities, concluding that prior to completing a transaction, these have no material impact on the Group due to the nature of its operations.

The Directors have also considered the ongoing operating costs expected to be incurred by the business over at least the next 12 months. Based on their review the Directors have concluded that there are no material uncertainties relating to going concern of the Group and as such the Financial Statements have been prepared on a going concern basis, which assumes that the Group will continue to be able to meet its liabilities as they fall due within the next 12 months from the date of approval of the Financial Statements.

 

Outlook The Directors believe that the current market backdrop provides a compelling need for a new approach to family-focussed financial solutions, with the opportunity to build a business through selective M&A and a strategic vision to address this. The Company continues to progress discussions regarding potential acquisition opportunities, as well as potential executive management appointments, which the Directors believe can deliver both the shareholder returns and broader stakeholder benefits that can be generated from a successful execution of the strategy.

 

RESPONSIBILITY STATEMENT

 

The Directors are responsible for preparing the consolidated financial statements in accordance with applicable laws and regulations, including the BVI Business Companies Act, 2004. The Directors have prepared the financial statements for the year to 30 June 2022, which give a true and fair view of the state of affairs of the Group and the loss of the Group for that year.

The Directors have acted honestly and in good faith and in what the Directors believes to be in the best interests of the Company.

The Directors have chosen to use International Financial Reporting Standards as adopted by the European Union ("IFRS") in preparing the Group's financial statements. International Accounting Standard 1 requires that financial statements present fairly for each financial year the group's financial position, financial performance and cash flows. This requires the faithful presentation of the effects of transactions, other events and conditions in accordance with the definitions and recognition criteria for assets, liabilities, income and expenses set out in the International Accounting Standards Board's "Framework for the preparation and presentation of financial statements". In virtually all circumstances, a fair presentation will be achieved by compliance with all applicable IFRS.

A fair presentation also requires the Directors to:

· select consistently and apply appropriate accounting policies;

· present information, including accounting policies, in a manner that provides relevant, reliable, comparable and understandable information;

· make judgements and accounting estimates that are reasonable and prudent;

· provide additional disclosures when compliance with the specific requirements in IFRS is insufficient to enable users to understand the impact of particular transactions, other events and conditions on the entity's financial position and financial performance;

· state that the Group has complied with IFRS, subject to any material departures disclosed and explained in the financial statements; and

· prepare the financial statements on the going concern basis unless it is inappropriate to presume that the company will continue in business.

The Directors are also required to prepare financial statements in accordance with the rules of the London Stock Exchange for companies trading securities on the Stock Exchange.

The Directors are responsible for keeping proper accounting records which disclose with reasonable accuracy at any time the financial position of the Group, for safeguarding the assets, for taking reasonable steps for the prevention and detection of fraud and other irregularities and for the preparation of financial statements.

Financial information is published on the Group's website. The maintenance and integrity of this website is the responsibility of the Directors; the work carried out by the auditor does not involve consideration of these matters and, accordingly, the auditor's accept no responsibility for any changes that may occur to the financial statements after they are presented initially on the website. Legislation in the British Virgin Islands governing the preparation and dissemination of financial statements may differ from legislation in other jurisdictions.

 

Directors' Responsibilities Pursuant to DTR4

In compliance with the Listing Rules of the London Stock Exchange, the Directors confirm to the best of their knowledge:

· The Financial Statements have been prepared in accordance with IFRS and give a true and fair view of the assets, liabilities, financial position and loss of the Group; and

· The management report includes a fair review of the development and performance of the business and the financial position of the Group, together with a description of the principal risks and uncertainties that it faces.

 

Independent Auditor

Baker Tilly Channel Islands Limited ("BTCI") was appointed as the Company's independent auditor during the year. BTCI has expressed its willingness to continue to act as auditor to the Group.

 

Disclosure of Information to Auditor

Each of the Directors in office at the date the Report of the Directors is approved, whose names and functions are listed in the Report of the Directors, confirm that, to the best of their knowledge:

· so far as they are aware, there is no relevant audit information of which the Group's auditor is unaware; and

· they have taken all the steps that they ought to have taken as a Director in order to make themself aware of any relevant audit information and to establish that the Group's auditor is aware of that information.

 

This Directors' Report was approved by the Board of Directors on 21 October 2022 and is signed on its behalf.

By Order of the Board

 

 

Mark Hodges Chairman21 October 2022

 

INDEPENDENT AUDITOR'S REPORT

 

Independent auditor's report to the members of Marwyn Acquisition Company II Limited

Opinion

We have audited the consolidated financial statements of Marwyn Acquisition Company II Limited (the "Company" and, together with its subsidiary, MAC II (BVI) Limited, the "Group"), which comprise the consolidated statement of financial position as at 30 June 2022, and the consolidated statement of comprehensive income, consolidated statement of changes in equity and consolidated statement of cash flows for the year then ended, and notes to the consolidated financial statements, including a summary of significant accounting policies.

In our opinion, the accompanying consolidated financial statements:

· give a true and fair view of the consolidated financial position of the Group as at 30 June 2022, and of its consolidated financial performance and its consolidated cash flows for the year then ended in accordance with International Financial Reporting Standards as adopted by the European Union (IFRSs); and

· have been prepared in accordance with the requirements of the BVI Business Company Act 2004, as amended.

Basis for opinion

We conducted our audit in accordance with International Standards on Auditing (UK) (ISAs) and applicable law. Our responsibilities under those standards are further described in the Auditor's Responsibilities for the Audit of the Consolidated Financial Statements section of our report. We are independent of the Group in accordance with the ethical requirements that are relevant to our audit of the consolidated financial statements in Jersey, including the FRC's Ethical Standard, and we have fulfilled our other ethical responsibilities in accordance with these requirements. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinion.

 

Key audit matters

Key audit matters are those matters that, in our professional judgement, were of most significance in our audit of the consolidated financial statements of the current period and include the most significant assessed risks of material misstatement (whether or not due to fraud) identified by us, including those which had the greatest effect on: the overall audit strategy; the allocation of resources in the audit; and directing the efforts of the engagement team. These matters were addressed in the context of our audit of the consolidated financial statements as a whole, and in forming our opinion thereon, and we do not provide a separate opinion on these matters.

Key audit matter

How our audit addressed the matter

Key observations communicated to those charged with governance

Equity and Warrants Issuance

The warrants issued to investors are subject to judgement in both classification and valuation.

The classification of the warrants is complex and must consider the nature and details of the instruments' contracts to determine the correct classification between equity and liabilities.

Further the fair value of these warrants was determined using the Black Scholes option pricing methodology which considered the exercise price, expected volatility, risk free rate, expected dividends and expected term of the warrants which is complex and involves estimates and judgements.

Financial Statement Impact:

£2,413,000

Fair Value of Warrants

 

The accounting policies on pages 22 and 23 sets out the treatment applied by management, and related disclosures are presented in Note 13.

Our audit procedures included, but were not limited to:

Classification:

We obtained an understanding of management's assessment for the classification of these instruments and the rationale for their classification.

We reviewed, in conjunction with our Technical Director the classification of these instruments and management's assessment in accordance with IAS 32 and IFRS 9 and we challenged management on their assessment.

Valuation:

We obtained the valuation report prepared by management's expert.

We performed the review of and validation of the valuation assumptions, methodology and calculations in respect of the valuation of the instruments and determined whether it was in accordance with the requirements of IFRS 9 and IFRS 13.

Disclosure:

We reviewed the relevant disclosures in the consolidated financial statements in accordance with the requirements of the IFRS as adopted by the European Union and performed a financial statement disclosure checklist utilising specialist software.

Based on the procedures performed, we are satisfied that management's judgements and estimates in respect of the valuation and classification of warrants for the year ended 30 June 2022 along with the related disclosures in the consolidated financial statements are appropriate.

We have nothing to report to those charged with governance from our testing.

 

Other matter

The financial statements for the period ended 30 June 2021 were audited by the previous auditor, as listed on page 35 of the financial statements, who expressed an unmodified opinion on those statements on 29 October 2021.

Our application of Materiality

Materiality for the consolidated financial statements as a whole was set at £211,000, determined with reference to a benchmark of Net Assets, of which it represents 2.5%.

In line with our audit methodology, our procedures on individual account balances and disclosures were performed to a lower threshold, performance materiality, so as to reduce to an acceptable level the risk that individually immaterial misstatements in individual account balances add up to a material amount across the consolidated financial statements as a whole.

Performance materiality was set at 70% of materiality for the consolidated financial statements as a whole, which equates to £147,700. We applied this percentage in our determination of performance materiality because we did not identify any factors indicating an elevated level of risk.

We reported to the Board of Directors any uncorrected omissions or misstatements exceeding £10,550, in addition to those that warranted reporting on qualitative grounds.

All Group companies were within the scope of testing by the Group audit team.

 

Conclusions relating to Going Concern

In auditing the consolidated financial statements, we have concluded that the Directors' use of the going concern basis of accounting in the preparation of the consolidated financial statements is appropriate.

Based on the work we have performed, we have not identified any material uncertainties relating to events or conditions that, individually or collectively, may cast significant doubt on the Group and Company's ability to continue as a going concern for a period of at least twelve months from when the consolidated financial statements are authorised for issue.

Our responsibilities and the responsibilities of the Directors with respect to going concern are described in the relevant sections of this report.

 

Other information

The other information comprises the information included in the annual report other than the consolidated financial statements and our auditor's report thereon. The Directors are responsible for the other information contained within the annual report. Our opinion on the consolidated financial statements does not cover the other information and, except to the extent otherwise explicitly stated in our report, we do not express any form of assurance conclusion thereon. Our responsibility is to read the other information and, in doing so, consider whether the other information is materially inconsistent with the consolidated financial statements or our knowledge obtained in the course of the audit, or otherwise appears to be materially misstated. If we identify such material inconsistencies or apparent material misstatements, we are required to determine whether this gives rise to a material misstatement in the consolidated financial statements themselves. If, based on the work performed, we conclude that there is a material misstatement of this other information, we are required to report that fact.

We have nothing to report in this regard.

 

Responsibilities of the Directors

As explained more fully in the Directors' responsibility statement set out on pages 10 and 11, the Directors are responsible for the preparation of consolidated financial statements that give a true and fair view in accordance with IFRSs, and for such internal control as the Directors determine is necessary to enable the preparation of consolidated financial statements that are free from material misstatement, whether due to fraud or error.

In preparing the consolidated financial statements, the Directors are responsible for assessing the Group and Company's ability to continue as a going concern, disclosing, as applicable, matters related to going concern and using the going concern basis of accounting unless management either intends to liquidate the Company or to cease operations, or has no realistic alternative but to do so.

The Directors are responsible for overseeing the Group's financial reporting process.

 

Auditor's responsibilities for the audit of the consolidated financial statements

Our objectives are to obtain reasonable assurance about whether the consolidated financial statements as a whole are free from material misstatement, whether due to fraud or error, and to issue an auditor's report that includes our opinion. Reasonable assurance is a high level of assurance, but is not a guarantee that an audit conducted in accordance with ISAs will always detect a material misstatement when it exists. Misstatements can arise from fraud or error and are considered material if, individually or in the aggregate, they could reasonably be expected to influence the economic decisions of users taken on the basis of these consolidated financial statements.

The extent to which our procedures are capable of detecting irregularities, including fraud, is detailed below:

· Enquiry of management to identify any instances of non-compliance with laws and regulations, including actual, suspected or alleged fraud;

· Reading minutes of meetings of the Board of Directors;

· Review of legal invoices;

· Review of management's significant estimates and judgements for evidence of bias;

· Review for undisclosed related party transactions;

· Obtained and reviewed bank statements as well as reviewed ledgers and minutes to ensure finance income is complete and as per our expectation;

· Using analytical procedures to identify any unusual or unexpected relationships; and

· Undertaking journal testing, including an analysis of manual journal entries to assess whether there were large and/or unusual entries pointing to irregularities, including fraud.

A further description of the auditor's responsibilities for the audit of the financial statements is located at the Financial Reporting Council's website at www.frc.org.uk/auditorsresponsibilities.

This description forms part of our auditor's report.

 

Other matters which we are required to address

We were appointed by Marwyn Acquisition Company II on 23 August 2022 to audit the consolidated financial statements. Our total uninterrupted period of engagement is 1 year.

The non-audit services prohibited by the FRC's Ethical Standard were not provided to the Group and we remain independent of the Group in conducting our audit.

 

Use of this Report

This report is made solely to the Members of the Company, as a body, in accordance with our letter of engagement dated 22 September 2022. Our audit work has been undertaken so that we might state to the Members those matters we are required to state to them in an auditor's report and for no other purpose. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than the Company and its Members, as a body, for our audit work, for this report, or for the opinions we have formed.

 

 

Sandy Cameron

For and on behalf of Baker Tilly Channel Islands Limited

Chartered Accountants

St Helier, Jersey

Date: 21 October 2022

 

CONSOLIDATED STATEMENT OF COMPREHENSIVE INCOME

 

 

 

Year ended 

30 June

2022

 

 

 

 Period ended

30 June

2021

Note

£'s

 

£'s

 

 

 

 

Administrative expenses

6

 

(1,314,001)

(636,100)

Operating loss

 

(1,314,001)

 

(636,100)

 

Finance income

14,483

4

Movement in fair value of warrants

13

(635,000)

-

Loss before income taxes

 

(1,934,518)

 

(636,096)

 

Income tax

7

-

-

Loss for the year/period

 

(1,934,518)

 

(636,096)

Total other comprehensive income

-

-

Total comprehensive loss for the year/period

 

(1,934,518)

 

(636,096)

 

 

 

 

 

Loss per share

 

 

£'s

 

£'s

Basic and diluted

8

(0.1523)

(0.2130)

 

The Group's activities derive from continuing operations.

The notes on pages 20 to 35 form an integral part of these Financial Statements.

 

CONSOLIDATED STATEMENT OF FINANCIAL POSITION

 

 

As at

30 June 2022

 

 

As at

30 June 2021

Assets

Note

£'s

£'s

 

 

 

 

 

Current assets

 

 

 

 

Other receivables

10

805,360

651,708

Cash and cash equivalents

11

10,254,198

12,255,387

Total current assets

11,059,558

 

 

12,907,095

 

 

 

 

 

Total assets

11,059,558

 

 

12,907,095

 

 

 

 

 

 

 

 

 

Equity and liabilities

 

 

 

 

 

Equity

 

 

 

 

Ordinary Shares

14

326,700

326,700

A Shares

14

10,320,000

10,320,000

Sponsor share

14

1

1

Share-based payment reserve

17

171,129

169,960

Accumulated losses

(2,570,614)

(636,096)

Total equity

8,247,216

 

 

10,180,565

 

 

 

 

 

Current liabilities

 

 

 

 

Trade and other payables

12

399,342

948,530

Warrants

13

2,413,000

1,778,000

Total liabilities

2,812,342

 

 

2,726,530

 

 

 

 

 

Total equity and liabilities

11,059,558

 

 

12,907,095

 

The notes on pages 20 to 35 form an integral part of these Financial Statements.

 

The Financial Statements were approved by the Board of Directors on 21 October 2022 and were signed on its behalf by:

 

Mark Hodges

Chairman

James Corsellis

Director

CONSOLIDATED STATEMENT OF CHANGES IN EQUITY

 

Note

 

Ordinary Shares

 

A Shares

 

Sponsor Share

 

Share based payment reserve

 

 

Accumulated

losses

 

Total equity

 

£'s

 

£'s

 

£'s

 

£'s

 

 

£'s

 

£'s

Balance at incorporation

-

 

-

 

-

 

-

 

 

-

 

-

Issuance of 1 ordinary share

1

-

-

-

-

1

Redesignation of 1 ordinary share

(1)

-

1

-

-

-

Issuance of 700,000 ordinary shares1

14

602,000

-

-

-

-

602,000

Share issue costs

14

(275,300)

-

-

-

-

(275,300)

Issuance of 12,000,000 A shares1

14

-

10,320,000

-

-

-

10,320,000

Total comprehensive loss for the period

-

-

-

-

(636,096)

(636,096)

Share-based payment charge

17

-

-

-

169,960

-

169,960

Balance at 30 June 2021

326,700

 

10,320,000

 

1

 

169,960

 

 

(636,096)

 

10,180,565

 

Note

 

Ordinary Shares

 

A Shares

 

Sponsor Share

 

Share based payment reserve

 

 

Accumulated

losses

 

Total equity

 

£'s

 

£'s

 

£'s

 

£'s

 

 

£'s

 

£'s

Balance at 1 July 2021

326,700

 

10,320,000

 

1

 

169,960

 

 

(636,096)

 

10,180,565

Total comprehensive loss for the year

-

-

-

-

(1,934,518)

(1,934,518)

Share-based payment charge

17

-

-

-

1,169

-

1,169

Balance at 30 June 2022

326,700

 

10,320,000

 

1

 

171,129

 

 

(2,570,614)

 

8,247,216

 

The notes on pages 20 to 35 form an integral part of these Financial Statements.

 

1The amounts raised from issuance of ordinary shares and matching warrants and A shares and matching A warrants were required to be split between equity and warrant liability based on the fair value attributable to these. Therefore, the amounts shown should be considered alongside the warrant liability as detailed in Note 13.

 

CONSOLIDATED STATEMENT OF CASH FLOWS

 

 

 

For the year ended

30 June

For the period ended 30 June

 

 

 

2022

2021

 

Note

 

£'s

£'s

Operating activities

Loss for the year

(1,934,518)

(636,096)

 

Adjustments to reconcile total operating loss to net cash flows:

Finance income

(14,483)

(4)

Fair Value loss on warrant provision

13

635,000

-

Share-based payment expense

17

1,169

154,960

Working capital adjustments:

(Increase) in other receivables

(153,652)

(651,708)

(Decrease)/Increase in trade and other payables

(596,188)

948,530

Net cash flows used in operating activities

 

(2,062,672)

(184,318)

 

Investing activities

Interest received

14,483

4

Net cash flows received from investing activities

 

14,483

 

 

4

 

Financing activities

Proceeds from issue of ordinary shares and matching warrants

13

-

700,001

Proceeds from issue of A shares and matching warrants

13

-

12,000,000

Proceeds from issue of ordinary A share capital in MAC II (BVI) limited

47,000

15,000

Costs directly attributable to equity raise

-

(275,300)

Net cash flows received from financing activities

 

47,000

 

 

12,439,701

 

 

 

Net (decrease)/increase in cash and cash equivalents

(2,001,189)

12,255,387

Cash and cash equivalents at the beginning of the year/period

12,255,387

-

Cash and cash equivalents at the end of the year/period

11

 

10,254,198

 

 

12,255,387

 

The notes on pages 20 to 35 form an integral part of these Financial Statements.

 

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

 

1. GENERAL INFORMATION

Marwyn Acquisition Company II Limited was incorporated on 31 July 2020 in the British Virgin Islands ("BVI") as a BVI business company (registered number 2040956) under the BVI Business Company Act, 2004. The Company was listed on the Main Market of the London Stock Exchange on 4 December 2020 and has its registered address at Commerce House, Wickhams Cay 1, P.O. Box 3140, Road Town, Tortola, VG1110, British Virgin Islands and UK establishment (BR022831) at 11 Buckingham Street, London WC2N 6DF.

The Company has been formed for the purpose of effecting a merger, share exchange, asset acquisition, share or debt purchase, reorganisation or similar business combination with one or more businesses. The Company has one subsidiary, MAC II (BVI) Limited (together with the Company, the "Group").

 

2. ACCOUNTING POLICIES

(a) Basis of preparation

The Financial Statements for the year ended 30 June 2022 have been prepared in accordance with International Financial Reporting Standards and IFRS Interpretations Committee interpretations as adopted by the European Union (collectively, "IFRS") and are presented in British pounds sterling, which is the presentational currency of the Group. The Financial Statements have been prepared under the historical cost basis, except for the revaluation of certain financial instruments that will be measured at fair value at the end of each reporting year, as explained in the accounting policies below. The comparative reporting period represents the period from incorporation, being 31 July 2020, to 30 June 2021.

The principal accounting policies adopted in the preparation of the Financial Statements are set out below. The policies have been consistently applied throughout the current and prior periods presented. 

(b) Going concern

The Financial Statements have been prepared on a going concern basis, which assumes that the Group will continue to be able to meet its liabilities as they fall due for the foreseeable future. The Directors have considered the financial position of the Group and have reviewed forecasts and budgets for a period of at least 12 months following the approval of the Financial Statements.

At 30 June 2022, the Group has net assets of £8,247,216 (2021: £10,180,565) and a cash balance of £10,254,198 (2021: £12,255,387). The Company has sufficient resources to continue to pursue its investment strategy which may include effecting a merger, share exchange, asset acquisition, share or debt purchase, reorganisation or similar business combination with one or more businesses. Subject to the structure of any acquisition, the Company may need to raise additional funds to finance the acquisition in the form of equity and/or debt.

The capital structure of the Company enables it to issue different types of shares in order to raise equity to fund an acquisition. As set out in the Management Report, during 2022, the Company has launched the Placing Programme, under which the Company has the ability to raise up to £500 million via the issuance of C Shares. No C Shares have yet been issued as at the date of these Financial Statements. The Company can also raise capital via the issuance of further ordinary shares or via the issuance of unlisted B shares which would be issued in conjunction with a private placement memorandum to qualifying institutional investors, and exchangeable into listed ordinary shares on re-admission. The ability of the Company to raise additional funds in relation to an acquisition may affect its ability to complete that acquisition. Other factors outside of the Company's control may also impact on the Company's ability to complete that acquisition. The key risks relating to the Company's ability to execute its stated strategy are set out on page 7. 

The Company also entered into a forward purchase agreement ("FPA") on 27 November 2020 with Marwyn Value Investors II LP (''MVI II LP'') of up to £20 million, which may be drawn for general working capital purposes and to fund due diligence costs. Any drawdown is subject to the prior approval of MVI II LP and the satisfaction of conditions precedent. At 30 June 2022 £12 million had been drawn down under the FPA. Whilst the FPA provides a mechanism for the Company to raise additional funds, as any drawdown is not under the exclusive control on the Company, all cashflow and working capital forecasts have been prepared without any further draw down on the FPA being assumed.

Furthermore, the Directors have considered the ongoing impact of the Covid-19 pandemic, conflict in Ukraine and current macro-economic factors on the Group's forecast cashflows and liabilities, concluding that prior to completing a transaction, these have no material impact on the Group due to the nature of its operations.

The Directors have also considered the ongoing operating costs expected to be incurred by the business over at least the next 12 months. Based on their review the Directors have concluded that there are no material uncertainties relating to going concern of the Group and as such the Financial Statements have been prepared on a going concern basis, which assumes that the Group will continue to be able to meet its liabilities as they fall due within the next 12 months from the date of approval of the Financial Statements.

(c) New standards and amendments to International Financial Reporting Standards

Standards, amendments and interpretations issued but not yet effective:

The following standards are issued but not yet effective. The Group intends to adopt these standards, if applicable, when they become effective. It is not currently expected that these standards will have a material impact on the Group.

Standard

Effective date

Onerous Contracts - Cost of Fulfilling a Contract (Amendments to IAS 37);

1 January 2022

Property, Plant and Equipment: Proceeds before Intended Use (Amendments to IAS 16);

1 January 2022

Annual Improvements to IFRS Standards 2018-2020 (Amendments to IFRS 1, IFRS 9, IFRS 16 and IAS 41);

1 January 2022

Amendments to IFRS 3: References to Conceptual Framework;

1 January 2022

Amendments to IAS 1 Presentation of Financial Statements: Classification of Liabilities as Current or Non-current*;

1 January 2023

Disclosure of accounting policies (Amendments to IAS 1);

1 January 2023

Extension of temporary exemption of applying IFRS 9 (Amendments to IFRS 4)

1 January 2023

Deferred Tax relating to Assets and Liabilities arising from a Single Transaction (Amendments to IAS 12);

1 January 2023

Initial Application of IFRS 17 and IFRS 9 - Comparative Information Amendment to IFRS 17);

1 January 2023

Definition of accounting estimates (Amendments to IAS 8);

1 January 2023

Amendments to IFRS 17 Insurance contracts;

1 January 2023

Amendment to IFRS 16 Leases: Lease Liability in a sale & leaseback*.

1 January 2024

* Subject to EU endorsement

 

(d) Basis of consolidation

Subsidiaries are entities controlled by the Company. Control exists when the Company is exposed to, or has rights to, variable returns from its involvement with the entity and has the ability to affect those returns through its power over the entity. The financial information of subsidiaries is fully consolidated from the date that control commences until the date that control ceases.

Intragroup balances, and any gains and losses or income and expenses arising from intragroup transactions, are eliminated in preparing the consolidated financial information.

 

(e) Financial instruments

A financial instrument is any contract that gives rise to a financial asset of one entity and a financial liability or equity instrument of another entity.

The Group initially recognises financial assets and financial liabilities at fair value. With the exception of warrants, financial assets and liabilities are subsequently remeasured at amortised cost using the effective interest rate.

 

Warrants

Warrants are accounted for as derivative liability instruments under IAS 32 and are measured at fair value at the date of issue and remeasured at each subsequent reporting date with changes in fair value being recognised in the Statement of Comprehensive Income. Fair value of the warrants has been calculated using a Black-Scholes option pricing methodology and details of the estimates and judgements used in determining the fair value of the warrants are set out in Note 3. The warrant liability will be derecognised when the liability is extinguished either through exercise or expiry.

(f) Cash and cash equivalents

Cash and cash equivalents comprise cash balances at banks.

 

(g) Equity

Ordinary shares, A shares and sponsor shares are classified as equity. Incremental costs directly attributable to the issue of new shares are recognised in equity as a deduction from the proceeds.

 

(h) Corporation tax

Corporation tax for the year presented comprises current and deferred tax. 

Current tax is the expected tax payable on the taxable income for the year, using tax rates enacted or substantially enacted at the balance sheet date. Deferred tax is provided using the balance sheet liability method, providing for temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes and the amounts used for taxation purposes. A deferred tax asset is recognised only to the extent that it is probable that future taxable profits will be available against which the asset can be utilised.

 

(i) Loss per ordinary share

The Group presents basic earnings per ordinary share ("EPS") data for its ordinary shares and A shares as disclosed in more detail in Note 8. Basic EPS is calculated by dividing the profit or loss attributable to ordinary shareholders of the Company by the weighted average number of ordinary shares outstanding during the year. Diluted EPS is calculated by adjusting the weighted average number of ordinary shares outstanding to assume conversion of all potential dilutive ordinary shares.

 

(j) Share based payments

The A1 ordinary shares and A2 ordinary shares in MAC II (BVI) Limited (the "Incentive Shares''), represent equity-settled share-based payment arrangements under which the Group receives services as a consideration for the additional rights attached to these equity shares.

Equity-settled share-based payments to Directors and others providing similar services are measured at the fair value of the equity instruments at the grant date. Fair value is determined using an appropriate valuation technique, further details of which are given in Note 17. The fair value is expensed, with a corresponding increase in equity, on a straight-line basis from the grant date to the expected exercise date. Where the equity instruments granted are considered to vest immediately as the services are deemed to have been received in full, the fair value is recognised as an expense with a corresponding increase in equity recognised at grant date.

(k) Warrants

On 4 December 2020, the Company issued 700,000 ordinary shares and matching warrants. Under the terms of the warrant instrument, warrant holders are able to acquire one ordinary share per warrant at a price of £1 per ordinary share, subject to a downward price adjustment depending on the price of future shares issued prior to or in conjunction with an initial acquisition. 

On 20 April 2021, the Company issued 12,000,000 A shares and matching A warrants at a price of £1 for one ordinary A share and matching A warrant. Under the terms of the warrant instrument, warrant holders are able to acquire one ordinary share per warrant at a price of £1 per ordinary share, subject to a downward price adjustment depending on the price of future shares issued prior to or in conjunction with an initial acquisition. 

Warrants are accounted for as derivative liability instruments under IAS 32 and are measured at fair value at the date of issue and each subsequent balance sheet date. Fair value of the warrants has been calculated using a Black-Scholes option pricing methodology and details of the estimates and judgements used in determining the fair value of the warrants are set out in Note 3.

 

3. CRITICAL ACCOUNTING JUDGEMENTS AND KEY SOURCES OF ESTIMATION UNCERTAINTY

The preparation of the Group's Financial Statements under IFRS requires the Directors to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities. Estimates and judgements are continually evaluated and are based on historical experience and other factors including expectations of future events that are believed to be reasonable under the circumstances. Actual results may differ from these estimates.

 

Key sources of estimation uncertainty

Valuation of warrants

The Company has issued matching warrants for both its issues of ordinary shares and A shares. For every share subscribed for, each investor was also granted a warrant ("Warrant") to acquire a further share at an exercise price of £1.00 per share (subject to a downward adjustment under certain conditions). In the prior period, the Warrants were exercisable at any time until five years after the issue date; effective 31 March 2022, the exercise date for the Warrants was extended to the 5th anniversary of a Business Acquisition, as detailed in Note 13. The Warrants are valued using the Black-Scholes option pricing methodology which considers the exercise price, expected volatility, risk free rate, expected dividends, and expected term of the Warrants.

 

Valuation of Incentive Scheme

The Company has issued Incentive Shares as part of the creation of a long-term incentive scheme which is valued using a Monte Carlo model. This model requires estimation and judgment surrounding the inputs of exercise price, expected volatility, risk free rate, expected dividends, and expected term of the Incentive Shares. The Ordinary A share liability held represents the subscription price of shareholders where there is an option to redeem the shares for cash should a shareholder be classified as a good leaver (refer to Note 17). Any redemption for cash in this scenario would be made at the lower of market value and the subscription price. The Directors estimate the subscription price to be materially equivalent to their underlying market value.

 

Other disclosures relating to the Group's exposure to risk and uncertainties are included in Note 16.

 

Critical accounting judgements

Classification of warrants

The Directors consider the warrants to represent a derivative liability due to the potential modification of the exercise price under certain conditions that the Directors believe are possible to occur. This modification results in the warrants failing the 'fixed for fixed' test, as outlined in IAS 32 para 16, which is required to recognise the warrants as equity instruments. This test requires the Company to provide a fixed number of shares for a fixed amount of cash on exercise of the warrants which would not be the case should the exercise price be modified. Accordingly, the warrants are recognised as derivative liabilities, whereby the fair value must be assessed at each balance sheet date with a review of the underlying inputs undertaken.

 

The initial fair value recognised for the warrants affects the corresponding entry in equity recognised for the issue of shares as the proceeds are required to be allocated between equity and liability as one share and matching warrant was issued for £1 in aggregate and therefore the proceeds received from the issue of equity is deemed to have been received for both the issue of the shares and the corresponding warrants.

 

Recognition and classification of costs relating to a possible further equity raise

In connection with a potential acquisition, the Company has continued to actively consider a possible further equity raise and on 29 March 2022, the Company announced that it was launching the Placing Programme. In relation to this, £723,592 (2021: £592,827) of costs incurred have been included in current asset deferred costs (refer to Note 10) The Directors have considered each of these costs to determine whether:

(i) they are directly attributable to the issuance of shares, and therefore would be taken as a deduction from equity on the issuance of further equity, or;

(ii) they should be taken directly to the Statement of Comprehensive Income as expenses.

At the year end, these costs are considered to be directly attributable to a future issuance of shares which the Directors intend to conclude within the next 12 months, at which point these costs would be subsequently reclassified from deferred costs to equity. However, there is no certainty that this capital raise will take place. If this further equity raise is not concluded, these costs will be expensed to the Statement of Comprehensive Income.

 

4. SEGMENT INFORMATION

The Board of Directors is the Group's chief operating decision-maker. As the Group has not yet acquired an operating business, the Board of Directors considers the Group as a whole for the purposes of assessing performance and allocating resources, and therefore the Group has one reportable operating segment.

 

5. EMPLOYEES AND DIRECTORS

The Group does not have any employees other than the Board of Directors. During the year ended 30 June 2022, the Company had three Directors: James Corsellis, Mark Brangstrup Watts and Mark Hodges. Mark Hodges was the only Director to receive remuneration under the terms of his director service agreement. The Company's subsidiary has issued Incentive Shares directly to Mark Hodges during the year ended 30 June 2022, he is currently the only Director to hold shares directly, the other Directors are beneficially interested through their indirect interest in Marwyn Long Term Incentive LP. Further detail is disclosed in Note 17.

(a) Employment costs for the Group during the year:

 

For the year

ended 30 June2022

 

For the period

ended 30 June2021

£'s

 

£'s

 

 

 

Wages and salaries

8,333

-

Social security costs

10,356

-

Signing on fee

61,238

-

Total employment costs expense

79,927

 

-

 

On the 19 June 2022, Mark Hodges was appointed as a Non-Executive Director and Chairman. Under the terms of his appointment letter, he is entitled to an annual fee of £250,000 and received a signing on fee of £61,238 of which £47,000 was used to pay the subscription for his Incentive Shares as further detailed in Note 17.

 

(b) Key management compensation

The Board considers the Directors of the Company to be the key management personnel of the Group.

 

(c) Employed persons

The average monthly number of persons employed by the Group (including Directors) during the year was as follows:

For the year

ended 30 June2022

 

 

For the period

ended 30 June2021

 number

 

number

Directors

2

2

2

 

2

 

6. ADMINISTRATIVE EXPENSES

For the year ended 30 June2022

 

 

 For the period

Ended 30 June

2021

£'s

 

 

£'s

Group expenses by nature

Personnel costs

79,927

-

Non-recurring project, professional and diligence costs

793,214

263,769

Professional support

410,298

178,347

Audit fees payable (Note 20)

20,000

35,000

Share-based payment expenses (Note 17)

1,169

154,960

Sundry expenses

9,393

4,024

1,314,001

 

 

636,100

 

7. INCOME TAX

For the year ended 30 June2022

 

 For the period

Ended 30 June

2021

£'s

 

£'s

Analysis of tax in year

Current tax on loss for the year

-

-

Total current tax

 

 

-

 

-

 

Reconciliation of effective rate and tax charge

For the year ended 30 June2022

 

 For the period Ended 30 June 2021

 

£'s

 

£'s

 

 

Loss on ordinary activities before tax

(1,934,518)

(636,096)

Loss multiplied by the rate of corporation tax in the UK of 19% (2021: 19%)

(367,558)

(120,859)

Effects of:

Other disallowable expenditure

131,780

29,973

Tax losses not utilised

 

 

235,778

 

90,886

Total taxation charge

 

 

-

 

-

 

The Group is tax resident in the UK. As at 30 June 2022, cumulative tax losses available to carry forward against future trading profits were £1,719,280, (2021: £478,343) subject to agreement with HM Revenue & Customs. There is currently no certainty as to future profits and no deferred tax asset is recognised in relation to these carried forward losses. Under UK Law, there is no expiry for the use of tax losses.

 

8. LOSS PER ORDINARY SHARE

Basic EPS is calculated by dividing the loss attributable to equity holders of the company by the weighted average number of ordinary shares and A shares in issue during the year. Diluted EPS is calculated by adjusting the weighted average number of ordinary shares and A shares outstanding to assume conversion of all dilutive potential ordinary shares and A shares. The Company being loss making in both this year and comparative period means that any exercise would be anti-dilutive.

The Company maintains different share classes, of which ordinary shares, A shares and sponsor shares were in issue in the current year and prior period. The key difference between ordinary shares and A shares is that the ordinary shares are traded with voting rights attached. The ordinary share and A share classes both have equal rights to the residual net assets of the Company, which enables them to be considered collectively as one class per the provisions of IAS 33. The sponsor share has no rights to distribution rights so has been ignored for the purposes of IAS 33. There were no B shares or C shares in issue in either the current year or prior period.

Refer to Note 13 (warrant liability) and Note 17 (share based payments) for instruments that could potentially dilute basic EPS in the future.

For the year

ended 30 June2022

 

For the period

ended 30 June

2021

Loss attributable to owners of the parent (£'s)

(1,934,518)

(636,096)

Weighted average in issue

12,700,000

2,986,827

Basic and diluted loss per ordinary share (£'s)

(0.1523)

(0.2130)

 

9. SUBSIDIARY

Marwyn Acquisition Company II Limited is the parent company of the Group, the Group comprises of Marwyn Acquisition Company II Limited and the following subsidiary as at 30 June 2022:

Company name

Nature of business

Country of incorporation

Proportion of ordinary shares held directly by parent

 

MAC II (BVI) Limited

Incentive vehicle

British Virgin Islands

100%

 

The share capital of MAC II (BVI) Limited consists of both ordinary shares and Incentive Shares. The Incentive Shares are non-voting and disclosed in more detail in Note 17.

 

There are no restrictions on the parent company's ability to access or use the assets and settle the liabilities of the parent company's subsidiary The registered office of MAC II (BVI) Limited is Commerce House, Wickhams Cay 1, P.O. Box 3140, Road Town, Tortola, VG1110, British Virgin Islands.

 

10. OTHER RECEIVABLES

As at30 June2022

 

As at

30 June

2021

 

£'s

 

£'s

Amounts receivable within one year:

Prepayments

17,634

4.658

Deferred costs

723,592

592,827

Due from related party (Note 18)

42,001

23,964

VAT receivable

22,133

30,259

 

 

805,360

 

651,708

There is no material difference between the book value and the fair value of the receivables. Receivables are considered to be past due once they have passed their contracted due date. Other receivables are all current.

 

11. CASH AND CASH EQUIVALENTS

As at30 June2022

 

As at

30 June

2021

£'s

 

£'s

Cash and cash equivalents

Cash at bank

10,254,198

12,255,387

10,254,198

 

12,255,387

Credit risk is managed on a group basis. Credit risk arises from cash and cash equivalents and deposits with banks and financial institutions. For banks and financial institutions, only independently rated parties with a minimum short-term credit rating of P-1, as issued by Moody's, are accepted.

 

12. TRADE AND OTHER PAYABLES

As at30 June2022

 

As at

30 June

2021

£'s

 

£'s

Amounts falling due within one year:

Trade payables

74,740

88,870

Due to a related party (Note 18)

109,735

41,355

Accruals

141,026

818,305

Other tax liabilities

26,841

-

A1 ordinary share liability (Note 17)

47,000

-

399,342

 

948,530

There is no material difference between the book value and the fair value of the trade and other payables.

All trade payables are non-interest bearing and are usually paid within 30 days.

 

13. WARRANT LIABLITY

 

 

£'s

Fair value of warrants:

At incorporation

-

Fair value of warrant issuances:

Warrant liability - ordinary warrants

98,000

Warrant liability - A warrants

1,680,000

Fair value of warrants at 30 June 2021

 

 

1,778,000

Fair value movement of warrants:

Warrant liability - ordinary warrants

35,000

Warrant liability - A warrants

600,000

Total fair value movement

635,000

Fair value of warrants at 30 June 2022

 

 

2,413,000

 

On 4 December 2020, the Company issued 700,000 ordinary shares and matching warrants at a price of £1 for one ordinary share and matching warrant. Under the terms of the warrant instrument ("Warrant Instrument"), warrant holders are able to acquire one ordinary share per warrant at a price of £1 per ordinary share, subject to a downward price adjustment depending on the price of future shares issued prior to or in conjunction with an initial acquisition. Warrants are fully vested at the year end.

On 20 April 2021, the Company issued 12,000,000 A shares and matching warrants at a price of £1 for one A share and matching A warrant. Under the terms of the A warrant instrument ("A Warrant Instrument"), warrant holders are able to acquire one ordinary share per warrant at a price of £1 per ordinary share, subject to a downward price adjustment depending on the price of future shares issued prior to or in conjunction with an initial acquisition.. Warrants are fully vested at the year end.

Effective 31 March 2022, both the Warrant Instrument and A Warrant Instrument were amended such that the long stop date was extended to the fifth anniversary of an initial acquisition by a member of the Group (which may be in the form of a merger, share exchange, asset acquisition, share or debt purchase, reorganisation or similar transaction) of a business ("Business Acquisition"). Previously the warrants were exercisable for 5 years from the date of issue.

Warrants are accounted for as a level 3 derivative liability instruments and are measured at fair value at grant date and each subsequent balance sheet date. The warrants and A warrants were separately valued at the date of grant. For both the warrants and A warrants, the combined market value of one share and one Warrant was considered to be £1, in line with the price paid by investors. A Black-Scholes option pricing methodology was used to determine the fair value, which considered the exercise prices, expected volatility, risk free rate, expected dividends and expected term. On initial recognition, Warrants had a fair value of 14p per Warrant. This remained unchanged until 30 June 2022 (the balance sheet date) where the fair value increased to 19p per Warrant. The Directors are responsible for determining the fair value of the warrants at each reporting date, the underlying calculations are prepared by Deloitte LLP. 

The key assumptions used in determining the fair value of the Warrants are as follows:

 

 

As at30 June 2022

 

As at30 June2021

 

 

 

 

 

Combined price of a share and warrant

£1

£1

Exercise price

£1

£1

Expected volatility

30.0%

25.0%

Risk free rate

2.17%

0.32%

Expected dividends

0.0%

0.0%

Expected term

5th anniversary of the completion of a Business Acquisition

5 years from the IPO and 4.4 years from the period end date

 

14. STATED CAPITAL

As at30 June2022

 

As at30 June2021

Issued and fully paid

£'s

 

£'s

700,000 ordinary shares of no par value

326,700

326,700

12,000,000 A shares of no par value

10,320,000

10,320,000

1 sponsor share of no par value

1

1

Total

10,646,701

10,646,701

On incorporation, the Company issued 1 ordinary share of no par value to MVI II Holdings I LP. On 30 September 2020, it was resolved that updated memorandum and articles ("Updated M&A") be adopted by the Company and with effect from the time the Updated M&A be registered with the Registrar of Corporate Affairs in the British Virgin Islands, the 1 ordinary share which was in issue by the Company be redesignated as 1 sponsor share of no par value (the "Sponsor Share").

On 4 December 2020, the Company issued 700,000 ordinary shares and matching warrants at a price of £1 for one ordinary share and matching warrant. As a result of the fair value exercise of the warrants, 14p was attributed to the warrants and therefore each ordinary share was initially valued at 86p per share. Costs of £275,300 directly attributable to this equity raise were taken against stated capital during the period ended 30 June 2021.

On 20 April 2021, the Company issued 12,000,000 A shares and matching A warrants at a price of £1 for one A share and matching A warrant. As a result of the fair value exercise of the A warrants, 14p was attributed to the A warrants and therefore each ordinary share was initially valued at 86p per share. There were no costs directly attributable to the issue of these shares.

There has been no issue of any share capital in the year ended 30 June 2022.

The ordinary shares and A shares are entitled to receive a share in any distribution paid by the Company and a right to a share in the distribution of the surplus assets of the Company on a winding-up. Only ordinary shares have voting rights attached. The Sponsor Share confers upon the holder no right to receive notice and attend and vote at any meeting of members, no right to any distribution paid by the Company and no right to a share in the distribution of the surplus assets of the Company on a summary winding-up. Provided the holder of the Sponsor Share holds directly or indirectly 5 per cent. or more of the issued and outstanding shares of the Company (of whatever class other than any Sponsor Shares), they have the right to appoint one director to the Board.

The Company must receive the prior consent of the holder of the Sponsor Share, where the holder of the Sponsor Share holds directly or indirectly 5 per cent. or more of the issued and outstanding shares of the Company, in order to:

• Issue any further Sponsor Shares;

• issue any class of shares on a non pre-emptive basis where the Company would be required to issue such share pre-emptively if it were incorporated under the UK Companies Act 2006 and acting in accordance with the Pre-Emption Group's Statement of Principles; or

• amend, alter or repeal any existing, or introduce any new share-based compensation or incentive scheme in respect of the Group; and

• take any action that would not be permitted (or would only be permitted after an affirmative shareholder vote) if the Company were admitted to the Premium Segment of the Official List.

The Sponsor Share also confers upon the holder the right to require that: (i) any purchase of ordinary shares; or (ii) the Company's ability to amend the Memorandum and Articles, be subject to a special resolution of members whilst the Sponsor (or an individual holder of a Sponsor Share) holds directly or indirectly 5 per cent. or more of the issued and outstanding shares of the Company (of whatever class other than any Sponsor Shares) or are a holder of incentive shares.

 

15. RESERVES

The following describes the nature and purpose of each reserve within shareholders' equity:

Accumulated losses

Cumulative losses recognised in the Consolidated Statement of Comprehensive Income.

Share based payment reserve

The share based payment reserve is the cumulative amount recognised in relation to the equity-settled share based payment scheme as further described in Note 17.

 

16. FINANCIAL INSTRUMENTS AND ASSOCIATED RISKS

The fair value measurement of the Group's financial and non-financial assets and liabilities utilities market observable inputs and data as far as possible. Inputs used in determining fair value measurements are categorised into different levels based on how observable the inputs used in the valuation technique utilised are (the "fair value hierarchy"):

Level 1: Quoted prices in active markets for identical items;

Level 2: Observable direct or indirect inputs other than Level 1 inputs; and

Level 3: Unobservable inputs, thus not derived from market data.

The classification of an item into the above levels is based on the lowest level of the inputs used that has a significant effect on the fair value measurement of the item. Transfers of items between levels are recognised in the year they occur.

The Group has the following categories of financial instruments as at 30 June 2022:

As at30 June2022

As at30 June2021

£'s

£'s

Financial assets measured at amortised cost

Cash and cash equivalents (Note 11)

10,254,198

12,255,387

Due from related party (Note 18)

42,001

23,964

 

10,296,199

12,279,351

 

 

Financial liabilities measured at amortised cost

 

Trade Creditors

74,740

88,870

Due to related party (Note 18)

109,735

41,355

Accruals

141,026

818,305

A1 ordinary share liability

47,000

-

372,501

948,530

 

Financial liabilities measured at measure at fair value to profit and loss

 

Financial liabilities measured at FVPL

 

Warrant Liability (Note 13)

2,413,000

1,778,000

2,413,000

1,778,000

All financial instruments are classified as current assets and current liabilities. There are no non-current financial instruments as at 30 June 2022.

For details of valuation techniques and significant unobservable inputs related to determining the fair value of the warrant liability, which is classified in level 3 of the fair value hierarchy, refer to Note 13.

The Group's risk management policies are established to identify and analyse the risks faced by the Group, to set appropriate risk limits and controls, and to monitor risks and adherence limits. Risk management policies and systems are reviewed regularly to reflect changes in market conditions and the Group's activities. Treasury activities are managed on a Group basis under policies and procedures approved and monitored by the Board.

As the Group's assets are predominantly cash and cash equivalents, market risk, and liquidity risk are not currently considered to be material risks to the Group. The Directors have reviewed the risk of holding a singular concentration of assets as predominantly all credit assets held are cash and cash equivalents, however, do not deem this a material risk. The risk is mitigated by all cash and cash equivalents being held with Barclays Bank plc, which holds a short-term credit rating of P-1, as issued by Moody's.

 

17. SHARE-BASED PAYMENTS

Management Long Term Incentive Arrangements

The Group has put in place a Long-Term Incentive Plan ("LTIP"), to ensure alignment between Shareholders, and those responsible for delivering the Company's strategy and attract and retain the best executive management talent.

The LTIP will only reward the participants if shareholder value is created. This ensures alignment of the interests of management directly with those of Shareholders.

On inception of the LTIP, Incentive Shares were issued by the Company's subsidiary to Marwyn Long Term Incentive LP ("MLTI"). On 17 June 2022, the Incentive Shares in the Company's subsidiary were redesignated into

A1 ordinary shares ("A1 Shares") and A2 ordinary shares ("A2 Shares"). Effective 19 June 2022, the Incentive shares issued to MLTI were redesignated as A2 Shares and the Company's Chairman Mark Hodges was issued 2,000 A1 Shares.

Preferred Return

The incentive arrangements are subject to the Company's shareholders achieving a preferred return of at least 7.5 percent per annum on a compounded basis on the capital they have invested from time to time (with dividends and returns of capital being treated as a reduction in the amount invested at the relevant time) (the "Preferred Return").

Incentive Value

Subject to a number of provisions detailed below, if the Preferred Return and at least one of the vesting conditions have been met, the holders of the Incentive Shares can give notice to redeem their Incentive Shares for ordinary shares in the Company ("Ordinary Shares") for an aggregate value equivalent to 20 per cent. of the "Growth", where Growth means the excess of the total equity value of the Company and other shareholder returns over and above its aggregate paid up share capital (20 per cent. of the Growth being the "Incentive Value").

Grant date

The grant date of the Incentive Shares will be the date that such shares are issued.

Service Conditions and Leaver Provisions

There are leaver provisions in relation to the A1 Shares which are set out in the subscription agreements entered into between the holders of the A1 Shares and MAC II (BVI) Limited.

If the holder leaves in circumstances in which he or she is deemed to be a "Good Leaver" (being any reason other than a bad leaver circumstance), then the holder of the A1 Shares will be entitled to the vested portion of the A1 Shares and in respect of the remainder of the A1 Shares the holder will be required to enter into documentation under which, at the election of the Company or MAC II (BVI) Limited the remainder of the A1 Shares will be compulsorily redeemed or acquired at the lower of the (i) the subscription price or (ii) the market value for such A1 Shares or the A1 Shares may be converted into ordinary shares in the Company. Any holder deemed to be a "Bad Leaver" (such as termination of employment for gross misconduct, fraud or criminal acts) will be required to sell his A1 Shares back to MAC II (BVI) Limited for a total consideration of £0.01. As there are conditions whereby the unvested portion of the A1 Shares can be redeemed or acquired at the lower of the (i) the subscription price or (ii) the market value for such A1 Shares, the amounts received from on the issue of A1 Shares is recognised as a liability in the Financial Statements.

Redemption / Exercise

Unless otherwise determined and subject to the redemption conditions having been met, the Company and the holders of the Incentive Shares have the right to exchange each Incentive Share for Ordinary Shares in the Company, which will be dilutive to the interests of the holders of Ordinary Shares. However, if the Company has sufficient cash resources and the Company so determines, the Incentive Shares may instead be redeemed for cash. It is currently expected that in the ordinary course Incentive Shares will be exchanged for Ordinary Shares. However, the Company retains the right but not the obligation to redeem the Incentive Shares for cash instead. Circumstances where the Company may exercise this right include, but are not limited to, where the Company is not authorised to issue additional Ordinary Shares or on the winding-up or takeover of the Company.

Any holder of Incentive Shares who exercises their Incentive Shares prior to other holders is entitled to their proportion of the Incentive Value to the date that they exercise but no more. Their proportion is determined by the number of Incentive Shares they hold relative to the total number of issued shares of the same class.

Vesting Conditions and Vesting Period

The Incentive Shares are subject to certain vesting conditions, at least one of which must be (and continue to be) satisfied in order for a holder of Incentive Shares to exercise its redemption right.

The vesting conditions are as follows:

i. it is later than the third anniversary of the initial Business Acquisition and earlier than the seventh anniversary of the Business Acquisition;

ii. a sale of all or substantially all of the revenue or net assets of the business of the Subsidiary in combination with the distribution of the net proceeds of that sale to the Company and then to its shareholders;

iii. a sale of all of the issued ordinary shares of the Subsidiary or a merger of the Subsidiary in combination with the distribution of the net proceeds of that sale or merger to the Company's shareholders;

iv. where by corporate action or otherwise, the Company effects an in-specie distribution of all or substantially all of the assets of the Group to the Company's shareholders;

v. aggregate cash dividends and cash capital returns to the Company's Shareholders are greater than or equal to aggregate subscription proceeds received by the Company;

vi. a winding-up of the Company;

vii. a winding-up of the Subsidiary; or

viii. a sale, merger or change of control of the Company.

If any of the vesting conditions described in paragraphs (ii) to (viii) above are satisfied before the third anniversary of the initial Business Acquisition, the Incentive Shares will be treated as having vested in full.

Holding of Incentive Shares

MLTI and Mark Hodges hold Incentive Shares entitling them to aggregate to 100 per cent. of the Incentive Value. Any future management partners or senior executive management team members receiving Incentive Shares will be dilutive to the interests of existing holders of Incentive Shares, however the share of the Growth of the Incentive Shares in aggregate will not increase.

The following shares were in issue at 30 June 2022:

Issue date

Name

Share designation at balance sheet date

Nominal Price

Issue price per A ordinary share

£'s

Number of A ordinary shares

Unrestricted market value at grant date £'s

IFRS 2 Fair value

£'s

25 November 2020

MLTI

A2

£0.01

7.50

2,000

15,000

169,960

19 June 2022

Mark Hodges

A1

£0.01

23.50

2,000

47,000

166,275

 

Valuation of Incentive Shares

Valuations were performed by Deloitte LLP using a Monte Carlo model to ascertain the unrestricted market value and the fair value at grant date. Details of the valuation methodology and estimates and judgements used in determining the fair value are noted herewith and were in accordance with IFRS 2 at grant date.

There are significant estimates and assumptions used in the valuation of the Incentive Shares. Management has considered at the grant date, the probability of a successful first Business Acquisition by the Company and the potential range of value for the Incentive Shares, based on the circumstances on the grant date.

The fair value of the Incentive Shares granted under the scheme was calculated using a Monte Carlo model with the following inputs:

Issue date

Name

Share designation at balance sheet date

Volatility

Risk-free rate

Expected term* (years)

25 November 2020

MLTI

A2

25%

0.0%

7.0

19 June 2022

Mark Hodges

A1

30%

2.2%

7.1

\* The expected term assumes that the Incentive Shares are exercised 7 years post acquisition.

The Incentive Shares are subject to the Preferred Return being achieved, which is a market performance condition, and as such has been taken into consideration in determining their fair value. The model incorporates a range of probabilities for the likelihood of an Business Acquisition being made of a given size.

Expense related to Incentive Shares

An expense of £1,169 (2021: £154,960) has been recognised in the Statement of Comprehensive Income in respect of the Incentive Shares issued during the year. There is a service condition associated with the shares issued to Mark Hodges, which requires the fair value charge associated with his shares to be allocated over the minimum vesting period. This vesting period is estimated to be 3.1 years from the date of grant.

There are no service conditions attached to the MLTI shares and as result the fair value at grant date was expensed to the profit and loss account on issue.

 

18. RELATED PARTY TRANSACTIONS

James Corsellis and Mark Brangstrup Watts are directors of the Company and Antoinette Vanderpuije is the Company Secretary of the Company. Funds managed by MIM LLP of which James Corsellis and Mark Brangstrup Watts are managing partners and Antoinette Vanderpuije is a partner, hold 75 per cent. of the Company's issued ordinary shares and warrants and 100% of the A shares and A warrants at the balance sheet date. During the year MIM LLP recharged expenses of £46,583 (2021: £11,805), of which £nil was outstanding at the year end (2021: £nil).

James Corsellis, Mark Brangstrup Watts and Antoinette Vanderpuije have an indirect beneficial interest in the Incentive Shares as described in Note 17 of the Financial Statements through their indirect interest in MLTI which owns 2,000 A2 Shares in the capital of MAC II (BVI) Limited.

James Corsellis and Mark Brangstrup Watts are the managing partners of Marwyn Capital LLP, and Antoinette Vanderpuije is also a partner. Marwyn Capital LLP provides corporate finance and managed services support, including named company secretary, to the Company. As part of this engagement a fee of £150,000 was charged in relation to the Company's equity raise on IPO, this fee was recognised and invoiced in the period ended 30 June 2021. On an ongoing basis a monthly fee of £10,000 per calendar month was charged for the provision of the corporate finance services, with such monthly fee increased to £25,000 effective 31 March 2022 on launch of the Placing Programme and £50,000 per calendar month from 19 June, being the date of Mark Hodge's appointment. As part of the Placing Programme a one-off fee of £325,000 was charged in respect of the services provided. Managed services support is charged by Marwyn Capital LLP on a time spent basis. The total amount charged in the year ended 30 June 2022 by Marwyn Capital LLP for fees was £553,641 (period ended 30 June 2021: £232,400) and they had incurred expenses on behalf of the Group, which were subsequently recharged of £299,434 (period ended 30 June 2021: £7,395). An amount payable to Marwyn Capital LLP of £97,575 (2021: £41,355) was outstanding as at the year end.

The Company has recharged costs associated with provision of project services of £16,039 (2021: £23,964) inclusive of VAT to Marwyn Acquisition Company III Limited ("MAC III"), of which £nil (2021: £23,964) was due to the Company at year end. MAC III is related to the Group through James Corsellis and Mark Brangstrup Watts being directors of MAC III.

The Company has recharged costs associated with provision of project services of £42,000 (2021: £nil) inclusive of VAT to MAC III (BVI) Limited ("MAC III (BVI)"), of which £42,000 (2021: £nil) was due to the Company at year end. MAC III (BVI) is related to the Group through James Corsellis and Mark Brangstrup Watts being directors of MAC III (BVI).

Mark Hodge's director compensation is disclosed in Note 5 and his holdings of Incentive Shares is disclosed in Note 17.

 

19. COMMITMENTS AND CONTINGENT LIABILITIES

There were no commitments or contingent liabilities outstanding at 30 June 2022 which would require disclosure or adjustment in these Financial Statements (30 June 2021: £Nil).

 

20. INDEPENDENT AUDITOR'S REMUNERATION

On 24 August 2022, the Group appointed Baker Tilly Channel Islands Limited as the Group's independent auditor, replacing Mazars LLP. Audit fees payable for the year ended 30 June 2022 are £20,000 (2021: £35,000 paid to Mazars LLP). Fees payable for the year ended 30 June 2022 in respect of any non-audit related procedures are £Nil (2021: £17,500 paid to Mazars LLP).

 

21. POST BALANCE SHEET EVENTS

There have been no material post balance sheet events that would require disclosure or adjustment in these Financial Statements (2021: None).

 

ADVISERS

 

Financial Adviser

BVI legal advisers to the Company

Investec Bank Plc

Conyers Dill & Pearman

30 Gresham St

Commerce House

London

Wickhams Cay 1

EC2V 7QN

Road Town

+44 (0)20 7597 4000

VG1110

Financial Adviser

Tortola

British Virgin Islands

Financial Adviser

Depository

N.M. Rothschild & Sons Limited

Link Market Services Trustees Limited

New Court, St Swithin's Lane

The Registry

London

34 Beckenham Road

EC4N 8AL

Beckenham

+44 (0)20 7280 5000

Kent

BR3 4TU

Company Broker

Registrar

WH Ireland Limited

Link Market Services (Guernsey) Limited

24 Martin Lane

Mont Crevelt House

London

Bulwer Avenue

EC4R 0DR

St Sampson

+44 (0)20 7220 1666

Guernsey

Company Broker

GY2 4LH

Company Secretary

Independent auditor

Antoinette Vanderpuije

For the year ended 30 June 2022

11 Buckingham Street

Baker Tilly Channel Islands Limited

London

First Floor, Kensington Chambers

WC2N 6DF

46-50 Kensington Place

Email: MAC2@marwyn.com

St Helier

Jersey, JE4 0ZE

 

Registered Agent and Assistant Company Secretary

For the period ended 30 June 2021

Conyers Corporate Services (BVI) Limited

Mazars LLP

Commerce House

Tower Bridge House

Wickhams Cay 1

St. Katharine's Way

Road Town

London

VG1110

E1W 1DD

Tortola

British Virgin Islands

English legal advisers to the Company

Registered office

Travers Smith LLP

Commerce House

10 Snow Hill

Wickhams Cay 1

London

Road Town

EC1A 2AL

VG1110

Tortola

British Virgin Islands

 

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
FR FLFELISLVFIF
Date   Source Headline
8th Mar 20247:00 amRNSInterim Financial Statements - 31 December 2023
28th Sep 20237:00 amRNSAnnual Financial Report
6th Jun 20237:00 amRNSAppointment of Will Self as CEO
31st Mar 20238:00 amRNSInterim Report for the period ended 31 Dec 2022
27th Mar 20237:00 amRNSAppointment of Will Self as CEO -Pensions Division
14th Nov 20224:30 pmRNSPublication of a Supplementary Prospectus
7th Nov 20227:00 amRNSBoard changes
24th Oct 20227:00 amRNSAnnual Financial Report
24th Aug 20224:45 pmRNSChange of Auditor
20th Jun 20227:00 amRNSAppointment of Mark Hodges as Chairman
31st Mar 20225:00 pmRNSInterim Report for the period ended 31 Dec 2021
31st Mar 20225:00 pmRNSREDEEMABLE SHARE CLASS PLACING PROGRAMME
29th Mar 20228:16 amRNSLAUNCH OF REDEEMABLE SHARE CLASS PLACING PROGRAMME
29th Oct 202112:03 pmRNSAudited Financial Statements
21st Oct 20213:00 pmRNSAuditor Appointment
30th Apr 202112:22 pmRNSTotal Voting Rights
20th Apr 20217:00 amRNS£12m subscription & £200m redeemable share issue
12th Apr 202112:15 pmRNSHolding(s) in Company
12th Apr 202111:53 amRNSHolding(s) in Company
31st Mar 20217:00 amRNSInterim Report for the period ended 31 Dec 2020
10th Dec 202012:00 pmRNSAppointment of Corporate Broker
7th Dec 20204:55 pmRNSHolding(s) in Company
7th Dec 20204:55 pmRNSHolding(s) in Company
7th Dec 20204:55 pmRNSHolding(s) in Company
7th Dec 20204:55 pmRNSHolding(s) in Company
7th Dec 20204:55 pmRNSHolding(s) in Company
4th Dec 20208:00 amRNSFirst day of dealings

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.